Oct 29, 2026, 21:40 UTC
Nippon Shokubai announced a share buyback of up to 3 million shares, or 2.0% of shares outstanding excluding treasury shares, for up to ¥6 billion.
Source:Sep 29, 2026, 07:00 UTC
Nippon Shokubai announced a technology partnership with Hiroshima University-launched drug discovery startup Palm X Therapeutics to develop nucleic acid medicines, verifying the applicability of Nippon Shokubai's drug delivery system materials to Palm X's nucleic acid drugs.
Source:Aug 27, 2026, 09:15 UTC
Nippon Shokubai announced on August 27 that it will increase the investment amount for its new lithium-ion battery materials plant in Kitakyushu City, scheduled to start operations in 2028, from approximately 37.5 billion yen to approximately 43 billion yen due to rising resource prices and construction costs.
Source: